US Stock Movement | PomDoctor (POM.US) Falls Nearly 4% in After-Hours Trading Following 0.75% Gain on Nasdaq Debut

Stock News

Oct 09

On Thursday, shares of PomDoctor (POM.US), a Chinese chronic disease management online platform, declined in after-hours trading. As of press time, the stock fell 3.72% to $3.88.

PomDoctor went public on the Nasdaq Stock Exchange on October 8, Eastern Time. The stock surged nearly 25% during intraday trading and closed up 0.75% on its IPO debut day.

The company completed its IPO by issuing 5 million American Depositary Shares (ADS) at a price of $4 per share, which was at the lower end of the $4-6 pricing range. The offering raised a total of $20 million.

As of December 31, 2024, the company had accumulated over 212,800 contracted physicians, issued more than 3 million prescriptions, and served 699,000 transactional patients (defined as patients who generated service consumption).

Joseph Stone Capital served as the sole bookrunner for the IPO transaction.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1117053116"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1117053116\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1117053116?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-09 15:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1117053116","market":"us","top_or_hot":-1,"title":"US Stock Movement | PomDoctor (POM.US) Falls Nearly 4% in After-Hours Trading Following 0.75% Gain on Nasdaq Debut","media":"Stock News","content":"<p>On Thursday, shares of PomDoctor (POM.US), a Chinese chronic disease management online platform, declined in after-hours trading. As of press time, the stock fell 3.72% to $3.88.</p>\n<p>PomDoctor went public on the Nasdaq Stock Exchange on October 8, Eastern Time. The stock surged nearly 25% during intraday trading and closed up 0.75% on its IPO debut day.</p>\n<p>The company completed its IPO by issuing 5 million American Depositary Shares (ADS) at a price of $4 per share, which was at the lower end of the $4-6 pricing range. The offering raised a total of $20 million.</p>\n<p>As of December 31, 2024, the company had accumulated over 212,800 contracted physicians, issued more than 3 million prescriptions, and served 699,000 transactional patients (defined as patients who generated service consumption).</p>\n<p>Joseph Stone Capital served as the sole bookrunner for the IPO transaction.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US Stock Movement | PomDoctor (POM.US) Falls Nearly 4% in After-Hours Trading Following 0.75% Gain on Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS Stock Movement | PomDoctor (POM.US) Falls Nearly 4% in After-Hours Trading Following 0.75% Gain on Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-10-09 15:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On Thursday, shares of PomDoctor (POM.US), a Chinese chronic disease management online platform, declined in after-hours trading. As of press time, the stock fell 3.72% to $3.88.</p>\n<p>PomDoctor went public on the Nasdaq Stock Exchange on October 8, Eastern Time. The stock surged nearly 25% during intraday trading and closed up 0.75% on its IPO debut day.</p>\n<p>The company completed its IPO by issuing 5 million American Depositary Shares (ADS) at a price of $4 per share, which was at the lower end of the $4-6 pricing range. The offering raised a total of $20 million.</p>\n<p>As of December 31, 2024, the company had accumulated over 212,800 contracted physicians, issued more than 3 million prescriptions, and served 699,000 transactional patients (defined as patients who generated service consumption).</p>\n<p>Joseph Stone Capital served as the sole bookrunner for the IPO transaction.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"QLD","symbol_name":"2倍做多纳斯达克100指数ETF-ProShares","start_time":0,"source_url":"","article_id":"1117053116","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1117053116","pubTimestamp":1759996218,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"On Thursday, shares of PomDoctor (POM.US), a Chinese chronic disease management online platform, declined in after-hours trading. As of press time, the stock fell 3.72% to $3.88. PomDoctor went...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159632":"纳斯达克","QLD":"2倍做多纳斯达克100指数ETF-ProShares","ARTL":"Artelo Biosciences, Inc.","NDX":"纳斯达克100指数","USAW.SI":"AMZN 3xLongSG261006","QID":"两倍做空纳斯达克指数ETF-ProShares","TSYW.SI":"TESLA 3xLongSG261006","POM":"石榴云医","BK4007":"制药","TQQQ":"纳指三倍做多ETF","03086":"华夏纳指","USJW.SI":"ALPHAB 3xLongSG261006","PSQ":"做空纳斯达克100指数ETF-ProShares","SQQQ":"纳指三倍做空ETF","QQQ":"纳指100ETF","NVIW.SI":"NVDA 3xLongSG261006",".IXIC":"NASDAQ Composite","BK1147":"投资银行业与经纪业"},"translate_title":"美股动向|PomDoctor(POM.US)盘后跌近4%，此前纳斯达克上市涨0.75%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159632":1,"QID":1,"QLD":1,"NVIW.SI":1,"SQQQ":1,".IXIC":1,"TQQQ":1,"PSQ":1,"QQQ":1,"USAW.SI":1,"USJW.SI":1,"MNQmain":1,"TSYW.SI":1,"03086":1,"NDX":1,"ARTL":1,"NQmain":1,"POM":1},"content_text":"On Thursday, shares of PomDoctor (POM.US), a Chinese chronic disease management online platform, declined in after-hours trading. As of press time, the stock fell 3.72% to $3.88.\nPomDoctor went public on the Nasdaq Stock Exchange on October 8, Eastern Time. The stock surged nearly 25% during intraday trading and closed up 0.75% on its IPO debut day.\nThe company completed its IPO by issuing 5 million American Depositary Shares (ADS) at a price of $4 per share, which was at the lower end of the $4-6 pricing range. The offering raised a total of $20 million.\nAs of December 31, 2024, the company had accumulated over 212,800 contracted physicians, issued more than 3 million prescriptions, and served 699,000 transactional patients (defined as patients who generated service consumption).\nJoseph Stone Capital served as the sole bookrunner for the IPO transaction.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}